As of 2025-07-07, the Fair Value of Biosyntech Inc (BSYI) is -4.02 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0 USD, the upside of Biosyntech Inc is -40188926.8%.
With the market price of 0 USD and our fair value calculation, Biosyntech Inc (BSYI) is not a good investment. Investing in BSYI stocks now will result in a potential loss of 40188926.8%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
Historical Earnings | ||||||
03-2005 | 03-2006 | 03-2007 | 03-2008 | 03-2009 | 5Y Avg | |
Net income | -5.14 | -6.85 | -8.11 | -9.27 | -12.94 | -8 |
YoY growth | -40.7% | -33.3% | -18.4% | -14.3% | -39.6% | -29.2% |
Market Cap (mil) | EPS | Fair Value | Upside | ||
a | |||||
Biosyntech Inc | 0 | -1.1 | -4.02 | -40188926.8% | |
Protalix Biotherapeutics Inc | 123 | 0 | 0.25 | -84.1% |
Market Cap (mil) | 0 |
P/E | - |
Forward P/E | - |
EPS | -1.09 |
Avg earnings growth rate | -29.2% |
TTM earnings | -13 |
Peter Lynch is one of the most legendary investors/fund managers of all time. His philosophy for stock investing is very simple and straightforward: he invests in stocks that are undervalued, meaning its P/E is less than or equal to its earnings growth rate. He believes that if a stock is trading at its fair value, the PEG ratio, which was also invented by him, should be 1.
Therefore, his formula to determine a company's fair value is:
Peter Lynch Fair Value = Earnings Growth Rate * EPS * PEG
PEG is set to 1 so we can ignore it in the calculation. Based on the formula, if the earnings growth rate of a company is 15%, Peter Lynch is willing to buy its share up to P/E = 15.